CBD Seeds

Kanaprima enters its first full-scale production cycle in 2025, so there are no historical results: all financial figures are projections, and net profit growth remains untested until commercial rollout begins. Success depends on achieving target yields, securing repeat buyers and navigating regulatory risks in the evolving European hemp market.

Client relationships are at an early stage — the initial buyers have validated lab-tested samples, with bulk order discussions to follow the first full-scale harvest. Seasonal production cycles expose cash flow to timing, and strategy, client relations and operations are concentrated in the founder.

The company expects significant revenue growth driven by expanded greenhouse capacity and market penetration in the premium segment starting in 2026. Gross profit is projected to improve through operational efficiency and differentiated pricing in 2027, when approximately one-third of seed volume is expected to be sold at a higher price tier. Net profitability is forecast to rise sharply, reflecting stable fixed costs, increased output and stronger pricing.

• Revenue more than triples over the period, driven by increased volumes and dual pricing in 2027.
• Gross profit nearly quadruples, supported by production scale and an improved pricing mix.
• Operating leverage improves as fixed costs stabilize after the initial infrastructure investment.

The production model is based on greenhouse agriculture with 2–3 harvests per year. Variable costs scale with volume, while fixed costs such as the land lease and infrastructure are expected to remain stable after the 2025–2026 investment phase.

In 2027 the company introduces a two-tier pricing model: the standard price remains at €0.13 per seed, while premium-grade seeds targeted at high-end European processors are priced at €0.25. Unit economics are expected to improve through both efficiency gains and higher-margin product segmentation, without proportional increases in core operating expenses.

Kanaprima’s growth strategy is a two-phase expansion between 2025 and 2027, focused on increasing production capacity and shifting sales toward premium European seed markets with higher price tolerance and certification standards. All actions are based on confirmed commercial interest and early client engagement.

Phase 1 — doubling production capacity (2025–2026)

• Increase total greenhouse area from 800 m² to 1,600 m².
• Procure new greenhouse and seed-processing equipment.
• Hire an agronomist, additional production staff and a sales manager.

Expected outcomes: annual seed output rising from 6,000,000 to 12,000,000 units, revenue doubling from €570,000 to €1,140,000, and better delivery capability for large-volume orders.

Phase 2 — entry into premium markets (2026–2027)

• Launch upgraded packaging and internal quality-control protocols.
• Use client feedback to adapt product presentation and documentation.
• Expand commercial outreach through referral networks and follow-on contracts.

Expected outcomes: a targeted share of seed output sold at €0.25 per unit to high-margin buyers in Switzerland, Germany and similar markets, revenue growing from €1,140,000 to €2,040,000, and a stronger position among certified suppliers of high-CBD hemp seeds.

Kanaprima operates in the European certified hemp seed market, supplying high-CBD varieties to industrial buyers. The segment is supported by regulatory alignment, sustained demand growth and expanding cross-border trade.

European market

The market is projected to reach €2.2 billion by 2025, with a CAGR of 15–20%. Main consumer markets include Germany, Switzerland and the Netherlands, while Bulgaria and Romania are emerging as efficient production bases.

• Demand for CBD-based wellness and nutraceutical products.
• Harmonized EU certification rules for seed quality and origin control.
• Growth in industrial applications such as textiles and bio-materials.
• Expansion of low-cost supply hubs in Eastern Europe.
• Export growth beyond the EU, including North America and Asia.

Switzerland

Switzerland is a key destination for premium-grade hemp seed exports. The domestic market is valued at over €450 million (2025 forecast) and grows at 10%+ a year. It offers clear regulation and high THC thresholds, strong demand for certified, lab-tested seeds and a preference for long-term contracts; Swiss buyers also serve as gateways to wider EU markets.

Bulgaria

Bulgaria is a production-oriented market with limited internal demand; its hemp-related economy, including cultivation and export, is estimated at €200+ million. Its advantages are competitive labour and facility costs, full EU certification alignment, upgraded infrastructure for drying, sorting and packaging hemp seeds, and straightforward access to Western Europe.

The requested €450,000 loan is secured by a combination of existing fixed assets and new equipment financed through the loan.

The total fixed asset collateral of €560,000 represents 124% coverage of the loan principal.

Kanaprima EOOD is requesting a loan of €450,000 to support production expansion and in-house quality control. The financing is allocated to fixed asset investments and the key inputs required for scaling operations:

• expand greenhouse infrastructure and double production capacity;
• establish a fully equipped laboratory for cannabinoid and germination testing;
• acquire essential raw materials and packaging upgrades for export;
• support payroll for key operational staff during the expansion period.

Planned asset acquisition

• Three greenhouse units (800 m² in total).
• Climate control and LED lighting systems.
• Drip irrigation, automation and environmental sensors.
• Laboratory equipment and infrastructure.
• Agricultural tools, seeding systems and drying racks.
• Organic fertilizers, biopesticides and upgraded seed stock.
• Packaging materials for export logistics.
• Salaries for an agronomist, a chemist, a sales manager and support staff.

Kanaprima EOOD is a licensed Bulgarian agricultural company focused on the cultivation and wholesale distribution of high-CBD hemp seeds. Operating in the upstream segment of the hemp supply chain, it specializes in certified seed production for industrial clients in the nutraceutical, cosmetic and pharmaceutical sectors. It does not engage in biomass processing or product manufacturing, keeping a lean operational focus for regulatory simplicity and cost efficiency.

Established in October 2024, the company obtained its cultivation licence from the Bulgarian Ministry of Agriculture in January 2025. The licence, valid through January 2028, permits the production of EU-certified hemp strains with a THC content below 0.3%.

Corporate identifiers: Kanaprima EOOD, a Bulgarian single-member limited liability company; EIK 208017612; registered office 7 Keshan Street, Oborishte District, Sofia 1527, Bulgaria.

Kanaprima is led by its founder and CEO, Vladislav Oleg Ivanov, a logistics and agricultural trade specialist with over 13 years of experience. He directly oversees commercial strategy, client relations and operational planning.

The company operates on a leased site comprising:

• three controlled-environment greenhouses (800 m² in total) for full-cycle seed cultivation;
• a dedicated 300 m² logistics area for drying, sorting and packaging;
• production capacity of 2–3 harvests per year, depending on the hemp variety;
• built-in scalability, with land available to add greenhouse units without relocating.

Initial test batches were carried out in early 2025, demonstrating the viability of the cultivation and post-harvest processes under controlled conditions. Full-scale operations are scheduled for later in the year and will validate performance at commercial scale.

Kanaprima operates as a certified seed supplier under a direct-export B2B model built around:

• direct sales to industrial processors, without third-party platforms;
• controlled-environment agriculture ensuring standardized seed output;
• seeds only — no biomass and no finished goods;
• no digital marketing, e-commerce, retail or trade fairs.

All output is intended for foreign processors, primarily in Western Europe. The model carries cyclical cash-flow exposure because of the seasonal production cycle.

After pilot production, Kanaprima shared lab-tested samples with potential clients, leading to early-stage validation and dialogue. Bulk order discussions are scheduled to follow the company’s first full-scale harvest in 2025.